project id: TCGA-ACC; case submitter id: TCGA-OR-A5LH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.21; rna integrity number: 7.6; age at index: 36; days to birth: -13182; days to death: 2385; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1969; year of death: 2011; age at diagnosis: 13182; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2731; initial weight: 130.0; sample id: f9c01615-0645-4d26-84e4-c5d55d9c9566; sample submitter id: TCGA-OR-A5LH-01A; portion id: ef60300b-e005-40a0-816d-1e96ce308639; portion submitter id: TCGA-OR-A5LH-01A-11; slide id: 5660c937-e167-44fc-97c1-de7f8e9bd37e; slide submitter id: TCGA-OR-A5LH-01A-01-TS1; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 40.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; section location: TOP;